MetLife Stock Price and Value Analysis

MetLife (NYSE:MET) with its current price, filing history and research links below. Our cash flow valuation does not fit this type of company, so there is no fair price.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Inside the MET Numbers

MET Price
(MetLife stock price per share)
$95.67
[?] PE Ratio versus Sector 5% lower than other Financial Services stocks
[?] PE Ratio versus Industry 21% lower than other Insurance - Life stocks
[?] Dividend Yield 2.38% (tax impact)
Shares Shorted 10,747,491

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 10,747,491 shares shorted. With 525,710,706 shares available for purchase and an average trading volume over the past 10 trading days of 3,265,800, it would take at least 3.3 days for all of the short holders to cover their shorts.

Why This Page Shows No Fair Price

Trendshare's cash flow valuation is built for operating companies, which sell goods or services and keep what is left after paying for the equipment they need. It does not fit banks, insurers, real estate investment trusts (REITs) or funds. Their cash flows include deposits, loan repayments, insurance premiums and distributions the company must pay out, so free cash flow does not measure what the business earns for its owners. For that reason this page shows no fair price, safety price or price comparison for MetLife. The price and basic facts above come from market data, and the filing history below comes from the company's own SEC reports.

To judge a company like this, read its filings on SEC EDGAR. Our investment guide explains the measures that suit each kind of company.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 5% below the average for stocks in the Financial Services sector.

Its trailing P/E ratio is 21% below the average for stocks in the Insurance - Life industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Insurance - Life industry, the ones closest in market capitalization to MetLife, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yield
MetLife (MET) 60,123 12.5 2.4%
Prudential Financial (PRU) 40,381 10.7 4.6%
Primerica (PRI) 8,702 11.3 1.7%
Voya Financial (VOYA) 8,530 15.3 1.9%
Genworth Financial (GNW) 2,776 75.8 -
Citizens (CIA) 158 18.4 -

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $47,152 million in 2007 and $77,084 million in 2025, a compound annual growth rate of 2.8% over 18 years.

Revenue rose 8.6% from 2024 to 2025.

Our estimated free cash flow was $17,092 million in 2025, 22.2% of revenue. In 2007 the estimated margin was 21.0%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2007 47,152 9,902 21.0%
2008 50,982 10,702 21.0%
2009 40,657 3,803 9.4%
2010 52,247 7,985 15.3%
2011 70,241 10,273 14.6%
2012 68,150 17,160 25.2%
2013 68,199 16,131 23.7%
2014 73,316 16,376 22.3%
2015 61,343 14,052 22.9%
2016 60,787 14,774 24.3%
2017 62,308 12,283 19.7%
2018 67,941 11,738 17.3%
2019 69,620 13,786 19.8%
2020 67,842 11,639 17.2%
2021 68,696 12,347 18.0%
2022 68,770 13,044 19.0%
2023 66,905 13,721 20.5%
2024 70,986 14,598 20.6%
2025 77,084 17,092 22.2%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $22,032 million against total liabilities of $716,245 million, or 3.1% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 96.1% of total assets in 2025, compared with 95.2% in 2008, an increase of 0.9 percentage points.

Stockholders equity was $28,680 million in 2025, compared with $23,985 million in 2008, a rise of 19.6%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 2.4% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2008 501,678 24,131 477,693 23,985
2009 539,314 10,024 507,577 33,498
2010 730,906 12,957 683,579 48,996
2011 796,226 10,461 738,232 57,889
2012 836,781 15,738 771,823 64,837
2013 885,296 7,585 822,313 62,096
2014 902,337 9,205 829,523 72,715
2015 877,933 11,182 809,288 68,568
2016 898,764 12,651 831,062 67,702
2017 719,892 12,701 661,022 58,870
2018 687,538 15,821 634,580 52,958
2019 740,463 16,598 674,081 66,382
2020 795,146 19,795 720,329 74,817
2021 759,708 20,047 709,695 67,749
2022 663,072 20,195 632,947 30,125
2023 687,584 20,639 657,331 30,253
2024 677,457 20,068 649,754 27,703
2025 745,166 22,032 716,245 28,680

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1099219.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

This analysis covers US companies that file 10-K annual reports. No fair price is shown for this company, because free cash flow does not describe banks, insurers, real estate investment trusts and funds. In the balance sheet and revenue tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: MET annual reports (10-K) on SEC EDGAR. Our editorial standards explain how Trendshare handles its sources and corrections.

Questions to Answer Before You Invest in MET

Does MetLife have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.